imatinib mesylate

Type: Keyphrase
Name: imatinib mesylate
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Methods and compositions for modulation of blood-neural barrier

Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic ... [Published PharmCast - Jul 17 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

[Comment] A modest but meaningful decision for Indian drug patents

On April 1, 2013, the Indian Supreme Court released its long-awaited decision on Novartis AG v Union of India & Others, better known as the Glivec (Gleevec in the USA; imatinib mesylate) patent case. Although neither the resounding victory for access ... [Published The Lancet online - Jun 27 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Patent Application Titled "Drug Delivery Medical Devices" Published Online

By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventor Papp, John E. (Temecua, CA), filed on February 10, 2014, was made available ... [Published Pharmacy Choice - Jun 25 2014]
First reported Jun 22 2014 - Updated Jun 22 2014 - 1 reports

Enough already with awareness; we need action

“Cancer doesn’t need more ribbons. It needs more survivors.”That hot-button blast in the full-page ad in The New York Times was followed by one even hotter: “Cancer doesn’t need more awareness. It needs more Gleevecs.”Oncologist Dr. Brian Druker led work—first ... [Published Michigan Live - Jun 22 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Two Cancer Stocks Take Shots On Goal: Echo He

Summary People attending ASCO are looking for specific, targeted treatment solutions, and for data that show significant improvements in efficacy over previously approved drugs. Generalists tend to chase momentum. If you're looking at a changed mood, ... [Published Seeking Alpha - Jun 19 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Dr. Richard Rockefeller (1949-2014)

In Memoriam: Dr. Richard Rockefeller, Founding Member of Doctors Without Borders USADr. Rockefeller Critical to Launch of Medical Humanitarian Organization in the United StatesDoctors Without Borders/Medecins Sans Frontieres (MSF) was deeply saddened ... [Published MSF-USA - Jun 17 2014]
First reported Jun 02 2014 - Updated Jun 02 2014 - 1 reports

GLEEVEC (Imatinib Mesylate) Tablet [Novartis Pharmaceuticals Corporation]

First reported May 19 2014 - Updated May 19 2014 - 1 reports

Novartis agrees Gleevec patent deal

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary to launch a generic version of blockbuster blood cancer drug Gleevec next year.The basic compound patent for Gleevec ... [Published BioPortfolio - May 19 2014]
Entities: Gleevec, Novartis AG, Patent
First reported May 15 2014 - Updated May 16 2014 - 1 reports

Sun, Novartis settle dispute

Mumbai, May 15: Sun Pharma has settled a legal dispute with Novartis over blockbuster leukemia drug Gleevec in the US. The development will pave the way for Dilip Shanghvi-promoted Sun Pharma to launch a generic version of the drug in the US in 2016. ... [Published Calcutta Telegraph - May 15 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Antibody-based arrays for detecting multiple signal transducers in rate circulating cells

The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis ... [Published PharmCast - Mar 12 2014]

Quotes

"In some embodiments, the present invention provides a medical device comprising a balloon and a drug delivery mechanism attached to the balloon. The medical device is in a size suitable for delivering a composition comprising at least one bioactive agent to a vessel in a lesion site of a vascular tissue. The balloon expands in response to pressure as to contact the wall of the vessel to open the vessel."

More Content

All (13) | News (10) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Methods and compositions for modulation of bloo... [Published PharmCast - Jul 17 2014]
[Comment] A modest but meaningful decision for ... [Published The Lancet online - Jun 27 2014]
Patent Application Titled "Drug Delivery Medica... [Published Pharmacy Choice - Jun 25 2014]
Enough already with awareness; we need action [Published Michigan Live - Jun 22 2014]
Two Cancer Stocks Take Shots On Goal: Echo He [Published Seeking Alpha - Jun 19 2014]
Dr. Richard Rockefeller (1949-2014) [Published MSF-USA - Jun 17 2014]
GLEEVEC (Imatinib Mesylate) Tablet [Novartis Ph... [Published DailyMed Drug Label Updates for the last seven ... - Jun 02 2014]
Novartis agrees Gleevec patent deal [Published BioPortfolio - May 19 2014]
Sun, Novartis settle dispute [Published Calcutta Telegraph - May 15 2014]
Antibody-based arrays for detecting multiple si... [Published PharmCast - Mar 12 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
BSE Healthcare index gains 22.6% during 2013, i... [Published PharmaBiz - Jan 03 2014]
Fact Sheet for SMS Pharmaceuticals Limited [Published Able2Act - May 06 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Comment] A modest but meaningful decision for ... [Published The Lancet online - Jun 27 2014]
On April 1, 2013, the Indian Supreme Court released its long-awaited decision on Novartis AG v Union of India & Others, better known as the Glivec (Gleevec in the USA; imatinib mesylate) patent case. Although neither the resounding victory for access ...
GLEEVEC (Imatinib Mesylate) Tablet [Novartis Ph... [Published DailyMed Drug Label Updates for the last seven ... - Jun 02 2014]
Updated Date: May 29, 2014 EST ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.